House Calls is healthcare business analysis from inside the room where policy, capital, and operating reality meet. Its conversations move slowly on purpose. A topic such as alternative revenue for health systems starts as a provider strategy question, then widens into fee-for-service dependence, rural access, urban strain, price controls, and the limits of ordinary supply-and-demand thinking in healthcare. A discussion of longevity clinics becomes less about lifestyle buzz and more about whether preventive health optimization can form a credible investable category. The recurring method is practical skepticism. New technology is not dismissed, but neither is it allowed to float above reimbursement, workflow, incentives, and scale. That makes the AI episodes feel less like futurism and more like market due diligence. The same habit shows up in conversations about M&A, where optimism around capital raising is weighed against administrative uncertainty, transaction timing, and investor selectivity. House Calls also has a policy spine. MedPAC, Medicare Advantage, PBMs, employer cost pressure, benefit design, network tightening, and capital redeployment are treated as linked parts of the same system rather than separate headlines. The show is comfortable with finance jargon, but it keeps returning to practical consequences: who pays, who consolidates, which markets get served, and where costs simply get moved around. Dave Johnson gives the series a conversational frame, while Cain Brothers bankers and conference panelists supply the sector detail. The tone is serious without becoming sterile. It can be blunt about failed transformation narratives, especially the long habit of waiting for a new technology, regulation, or business model to save healthcare. The best moments come when the conversation concedes complexity and then sharpens the point anyway. House Calls is for listeners who already know healthcare is hard and want better tools for thinking about why.